EXPRESSTEST
DEAD

Serial Number

97257578

Owner

Cignpost Investments Limited

Attorney

Charles P. Bacall

Filing Date

Feb 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EXPRESSTEST Trademark

Serial Number: 97257578

EXPRESSTEST is a trademark filed by Cignpost Investments Limited on February 8, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Cignpost Investments Limited (4 trademarks)

Building X92 Cody Technology Park
Farnborough, Hampshire GU140LX , GB

Entity Type: 99

Trademark Details

Filing Date

February 8, 2022

Registration Date

Not Registered

Goods & Services

Medical diagnostic services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical information; Medical consultation; Medical counselling; Medical testing; Medical services; Medical clinics; Medical screening; Medical evaluation services; Medical advisory services; Providing medical information; Medical analysis services; Medical information services; Medical care services; Medical treatment services; Compilation of medical reports; Medical clinic services; Medical equipment rental; Medical assistance services; Medical health assessment services; Medical information retrieval services; Medical examination of individuals; Rental of medical equipment; Rental of medical apparatus; Leasing of medical equipment; Issuing of medical reports; Provision of medical facilities; Provision of medical services; Conducting of medical examinations; Mobile medical clinic services; Medical and healthcare services; Genetic testing for medical purposes; DNA screening for medical purposes; Medical and health services relating to DNA, genetics and genetic testing; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical analysis services for the diagnosis of COVID 19; Medical analysis for the diagnosis and treatment of persons; RNA or DNA analysis for COVID 19 diagnosis and screening services; Medical testing services relating to the diagnosis and treatment of disease; COVID 19 screening services; on-site COVID 19 screening and testing services; temperature checking services as part of COVID 19 screening services; information, advisory and consultancy services in respect of the aforementioned services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 15, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 13, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 13, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 1, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2022 NWOS
NEW APPLICATION ENTERED
Feb 11, 2022 NWAP